APA (7th ed.) Citation

G, K., P, G., SG, G., R, J., S, A., S, B., . . . S, S. (2025). CRISPR/Cas9-engineering of Kell null erythrocytes to unveil host targeted irresistible antimalarial. Communications biology, 8(1), 730. https://doi.org/10.1038/s42003-025-07968-2

Chicago Style (17th ed.) Citation

G, Kumari, et al. "CRISPR/Cas9-engineering of Kell Null Erythrocytes to Unveil Host Targeted Irresistible Antimalarial." Communications Biology 8, no. 1 (2025): 730. https://doi.org/10.1038/s42003-025-07968-2.

MLA (9th ed.) Citation

G, Kumari, et al. "CRISPR/Cas9-engineering of Kell Null Erythrocytes to Unveil Host Targeted Irresistible Antimalarial." Communications Biology, vol. 8, no. 1, 2025, p. 730, https://doi.org/10.1038/s42003-025-07968-2.